Working as a Formulation Scientist

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com.

What will the world look like in 10 or 20 years? What will humankind need? What challenges might we face? What solutions might help us to overcome them? As a world-leading specialty chemicals company, all of us— roughly 32,000 people, active in over 100 markets, with annual sales of €12.2 bn in 2020—explore ways to improve life, today and tomorrow, by finding newer and better ways of answering questions like these.

Sun Pharmaceuticals Industries Inc. is the fourth largest generic pharmaceutical company in the world, and rapidly building brand presence. We manufacture, market and distribute pharmaceuticals to the nation’s largest wholesalers, distributors, warehousing and non-warehousing chain drugstores as well as managed care providers. Our goal is to continue to develop and market quality products that bring value to our customers and ultimately the patient. Current manufacturing capabilities allow Sun Pharma to develop products across most therapeutic categories. At Sun Pharma we believe our people are an invaluable asset. Our culturally diverse workforce is one of our biggest strengths, along with the rich experience they bring across varied skill-sets. We are proud that our global workforce is bound by our common values: Humility. Integrity. Passion. Innovation

HIMALAYA SINCE 1930 – THE STORY In the forests of Burma, a curious young man looked on, as villagers fed the roots of a local herb to calm a herd of agitated elephants. That man was Mr. M. Manal, the founder of Himalaya, and that herb was Rauwolfia Serpentina, the inspiration that led to the creation of Serpina®, the world's first natural antihypertensive drug, launched in 1934. Mr. Manal's dream of discovering the mysteries of nature began in the year 1930. He was determined to bring to people the promise of nature's healing power, harnessed through scientific research. Ninety years later, this vision has translated into Himalaya's mission of touching people's lives with the promise of Wellness in every Home and Happiness in every Heart.

Offices in over 30 countries Brand presence in over 100 global markets Team of over 10,000 people from 21 diverse nationalities Piramal Group is a global business conglomerate with diverse interests in Pharma, Financial Services and Real Estate. The Group has offices in over 30 countries and a global brand presence in more than 100 markets. Led by Mr. Ajay Piramal, the Chairman, Piramal Group is a torchbearer of trusteeship and responsible business ethos. Based on the philosophy of ‘Doing Well and Doing Good’, the Group continues to create long-term value for its stakeholders and the community at large. In the three decades of its existence, Piramal Group has pursued a twin strategy of both organic and inorganic growth. Driven by its core values, Piramal Group steadfastly pursues inclusive growth, while adhering to ethical and values-driven practices. Piramal Foundation, the philanthropic arm of the Piramal Group develops innovative solutions to resolve issues that are critical roadblocks towards unlocking India’s economic potential. Its sustainable development programmes in healthcare & nutrition, education and safe drinking water across 25 Indian states, largely in partnership with the central and state governments have impacted over 100 Million lives till date. Each social initiative nurtured by Piramal Foundation, addresses one of the three focus areas : Piramal Swasthya: Primary Healthcare and Nutrition Piramal School of Leadership: Education Leadership and Women & Youth Empowerment Piramal Sarvajal: Access to Safe Drinking Water

GSK is a global biopharma company with a special purpose – to unite science, technology and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organisation where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to impact the health of 2.5 billion people around the world in the next 10 years.